Genomic Grade Index (GGI): feasibility in routine practice and impact on treatment decisions in early breast cancer.

Genomic Grade Index (GGI) is a 97-gene signature that improves histologic grade (HG) classification in invasive breast carcinoma. In this prospective study we sought to evaluate the feasibility of performing GGI in routine clinical practice and its impact on treatment recommendations. ; Journal Article ; Research Support, Non-U.S. Gov't ; SCOPUS: ar.j ; info:eu-repo/semantics/published

Volltext
Verfasser: Metzger-Filho, Otto
Catteau, A.
Michiels, Stefan
Buyse, Marc
Ignatiadis, Michail
Saini, Kamal
Azambuja, Evandro
Fasolo, Virginie
Naji, Sihem
Canon, Jean Luc
Delree, Paul
Coibion, Michel
Cusumano, Pino
Jossa, Veronique
Kains, Jean-Pierre
Larsimont, Denis
Richard, Vincent
Faverly, Daniel
Cornez, Nathalie
Vuylsteke, Peter
Vanderschueren, Brigitte
Peyro-Saint-Paul, Hélène
Piccart-Gebhart, Martine
Sotiriou, Christos
Dokumenttyp: Artikel
Erscheinungsdatum: 2013
Schlagwörter: Cancérologie / Médecine pathologie humaine / Adult / Aged / 80 and over / Belgium / Breast Neoplasms -- genetics -- pathology / Carcinoma -- genetics / Comparative Genomic Hybridization / Decision Making / Feasibility Studies / Female / Genomics / Hospitals / Community / Humans / Middle Aged / Neoplasm Grading -- methods / Neoplasm Invasiveness / Neoplasm Metastasis / Nucleic Acid Hybridization / Oligonucleotide Array Sequence Analysis / Prognosis / Prospective Studies / Temperature
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27367950
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/157836